Long-term exposure to water contaminants, even below the regulatory limits, significantly increases the risk of chronic ...

Detailed price information for Edwards Lifesciences Corp (EW-N) from The Globe and Mail including charting and trades.

With investors and drugmakers increasingly eyeing the kidney disease space, a new company hopes to shed its underdog status ...

Most individuals with chronic kidney disease (CKD) are unaware of their disease, according to a KDIGO controversies conference on CKD prevention.

Pharma giants are sweating on the results of a federal government request for guidance on adding weight loss drugs to the ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Eli Lilly edges ahead of Novo Nordisk as the stronger obesity bet, backed by robust sales growth, pipeline depth and strategic momentum.

"Beyond the Scale" launches across Singapore with a clear and urgent call to focus on obesity as not a failure of willpower, but as a complex, chronic disease. The initiative invites the public to go ...

Raise awareness of obesity as a chronic, multifactorial disease. Reduce stigma and myths that hinder early care. Encourage timely, evidence-based conversations with healthcare professionals. Promote ...

Some women may be unaware they’re living with risks for heart disease, kidney disease and metabolic conditions like diabetes, ...

Altimmune shares cratered more than 50% on Thursday after its experimental obesity drug did not significantly improve liver ...